Participated in Pandorum Technologies' $18M Series B, led by Protons Corporate, for exosome-based regenerative tissue therapies.
Pandorum Technologies is a tissue engineering and regenerative medicine company focused on developing bioengineered products for corneal, liver, and lung regeneration
Pandorum Technologies is a tissue engineering and regenerative medicine company focused on developing bioengineered products for corneal, liver, and lung regeneration. Utilizing advanced technologies in biomaterials, cellular engineering, and exosome therapy, Pandorum aims to create innovative therapeutic solutions for various health conditions.